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Abstract
The aim of this work was to evaluate the
potential of moderate consumption of red wine
to modulate the intestinal inflammation
response on healthy humans. Fecal samples
from a human intervention study (n=34) were
collected before and after consumption of red
wine for 4 weeks, and 24 immune markers
including immunoglobulins, cytokines,
chemokines and growth factors, were
analysed. When considering the whole group
of case volunteers, almost no statistically sig-
nificant differences were found in the immune
markers after wine consumption. However, a
detailed exploration of the values differentiat-
ed a 6-volunteer subgroup that showed unusu-
ally high values of cytokines before wine con-
sumption. For this subgroup, wine consump-
tion significantly reduced the content of 16 out
of 24 markers down to usual values, especially
noticeable for cytokines related to the promo-
tion of initial inflammation (tumor necrosis
factor-alpha, interleukin 6 and interferon-
gamma). This study reveals, for the first time,
changes in the fecal profile of inflammatory
markers after moderate consumption of red
wine. 
Introduction
The human immune system is responsible
for protecting the body against the constant
threat of antigens from the surrounding envi-
ronment. Briefly, the intestinal immune
response is activated when an antigen is
transported through epithelium and contact
with immune cells (macrophages/monocytes
and T and B lymphocytes), which release solu-
ble immune markers such as immunoglobu-
lins and cytokines. Cytokines are a group of
low molecular weight proteins that act mediat-
ing complex interactions between the different
cells of the immune system. They play an
essential role in the homeostasis and regula-
tion of the local intestinal immune response.1,2
Cytokines can be divided into two categories:
those that up-regulate (pro-inflammatory) and
those that down-regulate (anti-inflammatory)
the inflammatory response. Inflammation is
characterized by the interplay between pro-
and anti-inflammatory cytokines,3 so an imbal-
ance of pro-inflammatory cytokines could have
an important role in the development of
inflammatory bowel diseases (IBDs).4,5 Since
any inflammatory marker produced locally as a
result of intestinal inflammation may leak into
the bowel lumen and be excreted in the stools,
the quantification of these inflammation
mediators [e.g. interferon-gamma (IFN-γ),
tumor necrosis factor-alpha (TNF-α), and
interleukin 8 (IL-8)] could be considered as an
useful and non-invasive technique to detect
inflammation and to ascertain the effect of
dietary interventions on it. 
In the last decade, a wide number of in vitro
studies have suggested the anti-inflammatory
role of wine and wine polyphenols, mainly in
relation to cardiovascular diseases, and partic-
ularly related to seric immune markers.6-10
However, in relation to intestinal inflamma-
tion, only in vitro experiments using colonic
cell models of inflammation have been per-
formed to investigate the effects of wine-
inherent polyphenols on intestinal inflamma-
tion.11-13 Therefore, in this work, the effect of
moderate consumption of wine on the human
gut immune status was investigated. For this
purpose, a wide spectrum of fecal immune
parameters, including several immunoglobu-
lins, cytokines, chemokines and growth fac-
tors, were analyzed in feces from healthy vol-
unteers (n=34) before and after moderate con-
sumption of red wine for 4 weeks. 
Materials and Methods
Human intervention study
A randomized and controlled intervention
study that consisted in the moderate consump-
tion of a young red wine by healthy volunteers
(n=42, 34 cases and 8 controls) was per-
formed.14 The wine used was a young Merlot
red wine (Penedês, Spain) (total polyphenol
content=1758 mg of gallic acid/L) kindly pro-
vided by Miguel Torres S.A. winery (Catalonia,
Spain). The study was divided into 2 consecu-
tive periods: a washout period (14 days) fol-
lowed by a 28 days period during which the vol-
unteers drank 250 mL/day of red wine, divided
into 2 doses. During both periods, participants
maintained the restriction of drinking any
other alcoholic beverage and followed a low-
polyphenols diet. The control group (n=8) fol-
lowed the same pattern as the case group
(n=34), with the exception that no wine was
ingested during this 4-week period. Feces were
immediately frozen and stored at -80ºC await-
ing analysis. The study was carried out accord-
ing to the rules and approval of the Bioethics
committee.Preparation of fecal solutions
Fecal samples (before and after interven-
tion) were thawed at room temperature and
weighted (0.1 g). Then, 1 mL of sterile phos-
phate buffer saline was added and solutions
vortexed and centrifuged (15 min, 14,000 rpm,
4ºC). Supernatants (~200 L) were collected
and used for the Multiplex Human Isotyping
assay.Detection and quantification ofimmune compounds in the fecalsamples
Fecal concentration of immunoglobulins
(Ig) (IgG1, IgG2, IgG3, IgG4, IgM and IgA) and
cytokines, chemokines and growth factors,
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including interleukins (IL) (IL-1β, IL-2, IL-4, IL-
5, IL-6, IL-7, IL-8, IL-10, IL-12, IL-13, and IL-17),
IFN-γ, TNF-α, growth-regulated oncogene-
alpha (Gro-α), monocyte chemoattractant pro-
tein-1 (MCP-1), macrophage inflammatory
protein-1β (MIP-1β), granulocyte colony stimu-
lating factor (G-CSF) and granulocyte-
macrophage colony stimulating factor (GM-
CSF) were determined in the fecal solutions
according to the methodology of Muñoz-
González et al.14 The Bio-Plex Pro Human
Isotyping assay and the human cytokine group
I and II assay kits (Bio-Rad Laboratories,
Hercules, CA, USA) were used following the
manufacturer’s protocol, in a Bioplex 200 sys-
tem instrument (Bio-Rad Laboratories).
Sample determinations were carried out in
duplicate. Standard curves of each analyte
were performed from triplicates of each
assayed concentration on each plate, with the
Bio-Plex Manager 6.0 software (Bio-Rad
Laboratories). The concentration of IgA in the
fecal solutions was determined using a specif-
ic enzyme-linked immunosorbent assay
(ELISA) kit (Cusabio Biotech Co., LTD.,
Wuhan, China), according to the manufactur-
er’s instructions.Statistical analysis
The statistical analysis was performed using
STATISTICA software. As the data were not
normally distributed, medians and interquar-
tile ranges (Q1 and Q3) were calculated for all
groups. Principal components analysis (PCA)
was used for exploration of the data and tenta-
tive classification of the case volunteers. For
assessing significant differences between low-
and high-cytokine-values subgroups before
intervention, the nonparametric Mann-
Whitney U test was performed. For assessing
significant differences before and after the
intervention period for any group/subgroup,
the nonparametric Wilcoxon test was applied.
In both cases, P<0.05 were considered to be
significant. 
Results
The preliminary analysis of the data
revealed a high inter-individual variability in
the fecal concentration of the immune com-
pounds analyzed (n=24), both before and after
the wine intervention (data not shown). When
all the volunteers who consumed wine (n=34)
were considered globally, no significant differ-
ences in any fecal immune parameter
(immunoglobulins, cytokines, chemokines and
growth factors) were observed between sam-
ples before and after wine consumption,
except for IL-13 (P=0.044). Interestingly, a
detailed exploration of the data indicated that
a group of 6 volunteers showed unusual high
values of cytokines (i.e., 120.9-3624 ng/g for
IFN-γ). This was supported by the PCA analysis
that showed that these 6 volunteers were clear-
ly separated from the rest according to the PC1
component (60.7% of the total variance
explained) that was correlated to the concen-
tration of cytokines. As a consequence, these
six volunteers exhibiting high fecal cytokine
values before intervention were taken as a
subgroup (high-cytokines-values subgroup)
clearly differentiated from the rest (low-
cytokines-values subgroup, n=28) of the inter-
vention group. For the first subgroup, statisti-
cally significant differences were found in 16
out of 24 immune markers (Figure 1). The
higher changes were found for cytokines TNF,
IL-6 and IFN, with 90-, 58- and 30-fold reduc-
tions, respectively, after wine intake. These
cytokines are considered as pro-inflammatory
cytokines and are particularly related to acute
phases of inflammation. On the contrary, for
the second subgroup (low-cytokine-values sub-
group, n=28), wine consumption did not lead
to significant changes in the fecal inflammato-
ry content, except for IL-13 (Figure 2). Finally,
for the control group, no significant differ-
ences were observed for any fecal immune
parameter (immunoglobulins, cytokines,
chemokines and growth factors) after the
intervention period (data not shown).
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Figure 1.  Representation of the median values (ng/g feces) of the
cytokines, chemokines and growth factors analyzed in the fecal
samples provided by the high-cytokine values subgroup (n=6). 
Figure 2. Representation of the median values (ng/g feces) of the
cytokines, chemokines and growth factors analyzed in the fecal
samples provided by the low-cytokine values subgroup (n=28). 
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Discussion
The anti-inflammatory in vivo effect of wine
intake has been only studied in relation to car-
diovascular diseases and particularly related to
seric immune markers. For example, Chiva-
Blanch et al.9 studied the effect of a red wine,
a red wine extract and a gin on a male popula-
tion with high cardiovascular risk, and
Sacanella et al.10 studied the effect of red and
white wine on healthy women. Both studies
reported a reduction in the concentration of
some cardiovascular-related immune markers
such as IL-6 and MCP-1 after wine intake. 
Our results revealed, for the first time, an
important decrease in the fecal content of
inflammatory markers after moderate con-
sumption of red wine, for those volunteers
showing unusually high basal values of
cytokines. Changes were especially noticeable
for those cytokines that promote initial inflam-
mation (TNF-α, IL-6 and IFN-γ). This could
have a beneficial effect on the intestinal
immunomodulation and inflammation in
healthy volunteers. The great number of
immune markers analyzed permitted to have a
complete overview of the immune status of the
volunteers. 
Cytokines play a key role in regulating the
intestinal immune response and inflammation
which is characterized by the loss of the phys-
iological equilibrium between pro- and anti-
inflammatory cytokines.3 It is worth to remark
that elevated values of fecal pro-inflammatory
cytokines have been related to the develop-
ment of IBDs and high levels of cytokines,
mainly TNF-α, IL-1ß and IL-6 have been found
in feces of IBD patients.15 Previous studies
with colonic cells models have shown anti-
inflammatory effects of wine extracts.1,2 These
studies have demonstrated significant reduc-
tions of cytokines, such as IL-6, IL-8 and TNF-
a, when application of red wine extracts to
induced-inflammation-colonic cells models.
Others authors have tested the anti-inflamma-
tory efficacy of individual wine phenolic com-
pounds [malvidin, genistein and (-)-epigallo-
catechin-3-gallate], which promoted decreases
in some cytokines, such as IL-6 or IL-8.11,16
Additionally, few in vivo studies with rats17,18
have found significant reductions in the
expression of IL-1ß, IL-8, IFN-γ and TNF-α, or
IL-1ß and TNF-α, respectively, when adminis-
tering hydrocaffeic acid or resveratrol, respec-
tively, to the dextran sulphate sodium-treated
rats used as a colitis model. Although most of
these studies were conducted with the original
phenolic forms present in wine or food, their
derived metabolites may exhibit similar or
enhanced anti-inflammatory properties.17
The wine used in this study was especially
rich in flavan-3-ols (270 mg/L),14 one of the
most abundant group of phenolic compounds
present in wine. In a previous work, we
observed that moderate consumption of this
red wine promoted a significant increase in
the content of phenolic metabolites (including
benzoic, mandelic, hippuric, phenylacetic,
phenylpropionic, cinnamic and valeric acids,
phenols, valerolactones, and others) in feces.14
Therefore, the decrease observed in several
cytokines after wine intake for the high-
cytokine-values subgroup (n=6) might be
related to the increase in the fecal content of
phenolic metabolites with potential anti-
inflammatory properties derived from the
metabolism of wine polyphenols. Currently, we
are carrying out further statistical analysis to
explore possible relationships between con-
tents of immune parameters and contents of
phenolic metabolites present in feces as a con-
sequence of wine consumption.19
Conclusions
In conclusion, this study with healthy volun-
teers showed, for the first time, that moderate
consumption of a phenolic-rich red wine can
favorably modulate the immune intestinal
response in vivo by inducing gut anti-inflam-
matory effects in hosts with an asymptomatic
gut inflammation. 
References 
1. Romier-Crouzet B, Van De Walle J, During
A, et al. Inhibition of inflammatory media-
tors by polyphenolic plant extracts in human
intestinal Caco-2 cells. Food Chem Toxicol
2009;47:1221-30. 
2. Angel-Morales G, Noratto G, Mertens-Talcott
S. Red wine polyphenolics reduce the
expression of inflammation markers in
human colon-derived CCD-18Co myofibrob-
last cells: potential role of microRNA-126.
Food Funct 2012;3:745-52. 
3. Cavaillon J. Pro- versus anti-inflammatory
cytokines: myth or reality. Cell Mol Biol
2001;47:695-702. 
4. Ardizzone S, Porro G. Biologic therapy for
inflammatory bowel disease. Drugs
2005;65:2253-86. 
5. Wall G, Heyneman C, Pfanner T. Medical
options for treating Crohn’s disease in
adults: focus on antitumor necrosis factor-
alpha chimeric monoclonal antibody.
Pharmacotherapy 1999;19:1138-52. 
6. Avellone G, Di Garbo V, Campisi D, et al.
Effects of moderate Sicilian red wine con-
sumption on inflammatory biomarkers of
atherosclerosis. Eur J Clin Nutr 2006;60:41-
7. 
7. Li H, Foerstermann U. Red wine and cardio-
vascular health. Circ Res 2012;111:959-61. 
8. Chiva-Blanch G, Arranz S, Lamuela-
Raventos RM, Estruch R. Effects of wine,
alcohol and polyphenols on cardiovascular
disease risk factors: evidences from human
studies. Alcohol Alcoholism 2013;48:270-7. 
9. Chiva-Blanch G, Urpi-Sarda M, Llorach R, et
al. Differential effects of polyphenols and
alcohol of red wine on the expression of
adhesion molecules and inflammatory
cytokines related to atherosclerosis: a ran-
domized clinical trial. Am J Clin Nutr
2012;95:326-34. 
10. Sacanella E, Vazquez-Agell M, Mena MP, et al.
Down-regulation of adhesion molecules and
other inflammatory biomarkers after moder-
ate wine consumption in healthy women: a
randomized trial. Am J Clin Nutr
2007;86:1463-9. 
11. Bognar E, Sarszegi Z, Szabo A, et al.
Antioxidant and anti-inflammatory effects
in RAW264.7 macrophages of malvidin, a
major red wine polyphenol. PLoS One
2013;8:e65355. 
12. Biasi F, Guina T, Maina M, et al. Phenolic
compounds present in Sardinian wine
extracts protect against the production of
inflammatory cytokines induced by oxys-
terols in CaCo-2 human enterocyte-like
cells. Biochem Pharmacol 2013;86:138-45. 
13. Nunes C, Ferreira E, Freitas V, et al.
Intestinal anti-inflammatory activity of red
wine extract: unveiling the mechanisms in
colonic epithelial cells. Food Funct
2013;4:373-83. 
14. Muñoz-Gonzalez I, Jimenez-Girón A,
Martin-Alvarez PJ, et al. Profiling of micro-
bial-derived phenolic metabolites in human
feces after moderate red wine intake. J Agr
Food Chem 2013;61:9470-9. 
15. Nikolaus S, Raedler A, Schreiber S.
Immunosenescence of the GI immune sys-
tem: increased secretion of proinflammato-
ry cytokines by LPMNC. Gastroenterology
1998;114:A897. 
16. Sergent T, Piront N, Meurice J, et al. Anti-
inflammatory effects of dietary phenolic
compounds in an in vitro model of inflamed
human intestinal epithelium. Chem Biol
Interact 2010;188:659-67. 
17. Larrosa M, Luceri C, Vivoli E, et al.
Polyphenol metabolites from colonic micro-
biota exert anti-inflammatory activity on dif-
ferent inflammation models. Mol Nutr Food
Res 2009;53:1044-54.
18. Sanchez-Fidalgo S, Cardeno A, Villegas I, et
al. Dietary supplementation of resveratrol
attenuates chronic colonic inflammation in
mice. Eur J Pharmacol 2010;633:78-84. 
19. Muñoz-González I, Espinosa-Martos I,
Rodríguez JM, et al. Moderate consumption
of red wine can modulate human intestinal
inflammatory response. J Agr Food Chem
2014:62:10567-75.
                             Article
